|
Sign In to gain access to subscriptions and/or personal tools.
|
Expanding Spectrum of Encephalitis With NMDA Receptor Antibodies in Young Children
Axel Lebas, MD1*,
Béatrice Husson, MD2,
Adrien Didelot, MD3,
Jerôme Honnorat, MD, PhD3,
and
Marc Tardieu, MD1
1 Assistance Publique-Hôpitaux de Paris, Service de neurologie pédiatrique et Centre de Référence des maladies inflammatoires du cerveau, Hôpital Bicêtre, France
2 Assistance Publique-Hôpitaux de Paris, Service de radiologie pédiatrique, CHU Bicêtre, Le Kremlin-Bicêtre, France
3 Centre de Référence de diagnostic et de traitement des syndromes neurologiques paranéoplasiques, Hospices Civils de Lyon, and INSERM U842, France
* To whom correspondence should be addressed. E-mail: axel.lebas{at}bct.aphp.fr.
 |
Abstract |
|---|
The authors report here 2 cases of subacute-onset encephalitis with N-methyl-D-aspartate (NMDA) receptor antibodies. One had a paraneoplastic syndrome associated with a neuroblastoma, whereas the other had no primary tumor. This disease was originally described as a paraneoplastic syndrome in young women with ovarian teratoma. The clinical features of both children resembled the typical symptoms reported for older patients with this disease: psychomotor deterioration, movement disorders, and seizures. One of the reported cases is the first known case of paraneoplastic encephalitis with NMDA antibodies in a child with neuroblastoma. Both cases described here were younger than any of the previously reported cases. Consistent with recently published series, this report suggests that the spectrum of symptoms of encephalitis with NMDA receptor antibodies is probably wider than previously thought.
First published on October 15, 2009 Journal of Child Neurology 2009, doi:10.1177/0883073809343319

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|